HEPATIC NEUROENDOCRINE TUMOUR

This adverse event was reported 37 times

These drugs are most commonly taken by patients reporting HEPATIC NEUROENDOCRINE TUMOUR:

# Drug Count
0 EVEROLIMUS 5
1 OCTREOTIDE ACETATE 5
2 METFORMIN 4
3 RAMIPRIL 4
4 RIBOCICLIB 4
5 CAPECITABINE 3
6 CLOPIDOGREL 3
7 CLOPIDOGREL BISULFATE 3
8 EXEMESTANE 3
9 LAMOTIRIGINE 3
See all common drugs associated with HEPATIC NEUROENDOCRINE TUMOUR

HEPATIC NEUROENDOCRINE TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) 1 0.0021
1 ELIGLUSTAT 1 0.0006
2 TESTOSTERONE UNDECANOATE 1 0.0005
3 LUTETIUM LU 177 DOTATATE 2 0.0003
4 BARICITINIB 1 0.0003
5 PYRIDOSTIGMINE BROMIDE ORAL 1 0.0003
6 APREPITANT 2 0.0003
7 LANREOTIDE ACETATE 2 0.0003
8 GRANISETRON HYDROCHLORIDE 2 0.0002
9 DAROLUTAMIDE 1 0.0002
See all drugs enriched for association with HEPATIC NEUROENDOCRINE TUMOUR